≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other disorders of bone density and structure

EFO MESH Endpoint Browser PheWeb

M13_BONEDENSOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — M85
  • Hospital discharge: ICD-9 — 733[2-3]|7335
  • Cause of death: ICD-10 — M85
  • Cause of death: ICD-9 — 733[2-3]|7335

2 out of 7 registries used, show all original rules.

986

4. Check minimum number of events

None

986

5. Include endpoints

None

986

6. Filter based on genotype QC (FinnGen only)

986

Control definitions (FinnGen only)

Control exclude
M13_OSTEOCHONDRO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M80-M85
Name in latin
Aliae perturbationes densitatis et structurae ossium

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8060 4419 3617
Only index persons 7643 4236 3407
Unadjusted period prevalence (%)
Whole population 0.11 0.13 0.10
Only index persons 0.14 0.16 0.13
Median age at first event (years)
Whole population 39.96 45.13 33.56
Only index persons 39.69 44.77 33.38

-FinnGen-

Key figures

All Female Male
Number of individuals 986 636 350
Unadjusted period prevalence (%) 0.19 0.22 0.15
Median age at first event (years) 45.13 44.80 45.73

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
887
Matched controls
8870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M85.8
ICD-10 Finland
Other specified disorders of bone density and structure
4281.0
323.0
304
*
M85.4
ICD-10 Finland
Solitary bone cyst
+∞
183.9
170
*
M85.9
ICD-10 Finland
Disorder of bone density and structure, unspecified
1303.6
119.7
114
*
M85.6
ICD-10 Finland
Other cyst of bone
+∞
96.6
91
*
M85.0
ICD-10 Finland
Fibrous dysplasia (monostotic)
+∞
78.3
74
*
M85.5
ICD-10 Finland
Aneurysmal bone cyst
+∞
47.3
45
*
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
19.5
47.0
72
40
M85.3
ICD-10 Finland
Osteitis condensans
+∞
42.0
40
*
7332X
ICD-9 Finland
Other disorders of bone and cartilage, Cyst of bone[CYSTA OSSIS ALIA]
+∞
34.6
33
*
9102
FHL
Trepanation or removal of the local bone process
26.2
32.6
45
18
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
15.0
32.3
54
38
7332A
ICD-9 Finland
Other disorders of bone and cartilage, Cyst of bone[CYSTA SOLITARIA OSSIS]
+∞
31.4
30
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
13.3
26.9
47
37
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
10.8
26.8
52
51
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
96.2
25.8
28
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
23.8
388
2384
M25.5
ICD-10 Finland
Pain in joint
2.2
22.2
293
1628
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
16.8
19.7
31
19
M05BA04
ATC
alendronic acid; oral
4.0
18.7
77
205
N03AX12
ATC
gabapentin; oral
2.4
16.8
151
687
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
+∞
16.7
16
*
N03AX16
ATC
pregabalin; oral
2.1
16.6
216
1170
M01AC06
ATC
meloxicam; systemic, rectal
1.9
15.9
317
2018
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.9
15.7
100
372
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
7.3
15.2
36
51
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
14.9
238
1390
NDK99
NOMESCO Finland
Other operation on bone of hand or wrist
57.6
14.8
17
*
NGK05
NOMESCO Finland
Partial or total excision of bone of lower leg
57.6
14.8
17
*
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
14.4
315
2053
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
22.7
14.3
20
9
318
Kela drug reimbursment
Teriparatide
+∞
13.6
13
*
M54.5
ICD-10 Finland
Low back pain
1.8
13.5
298
1940
SPAT1153
SPAT
Removal of sutures
1.8
13.2
263
1652
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
12.8
401
2893
NFK10
NOMESCO Finland
Fenestration or partial or total excision of bone of femur
70.8
12.6
14
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.4
12.6
62
193
H05AA02
ATC
teriparatide; parenteral
+∞
12.5
12
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
12.2
321
2193
J01MA02
ATC
ciprofloxacin; systemic
1.7
12.1
303
2038
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
12.0
101
443
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
47.3
11.9
14
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
11.9
248
1574
J01DB01
ATC
cefalexin; oral
1.8
11.9
709
6097
M01AB05
ATC
diclofenac; systemic, rectal
1.7
11.8
560
4494
N02BE01
ATC
paracetamol; systemic, rectal
1.9
11.8
734
6392
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
11.7
88
362
M05BX04
ATC
denosumab; parenteral
4.5
11.7
41
95
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
11.7
320
2202
M80, M85
ICD-10 Finland
NA
+∞
11.5
11
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.5
11.2
91
390
ZXA00
NOMESCO Finland
Right side
1.8
10.8
217
1353
M05BA07
ATC
risedronic acid; oral
4.5
10.8
37
84
M01AH05
ATC
etoricoxib; oral
1.6
10.8
497
3913
B01AB05
ATC
enoxaparin; parenteral
1.8
10.7
229
1460
A02BC02
ATC
pantoprazole; systemic
1.6
10.5
511
4068
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.1
10.5
119
596
M79.6
ICD-10 Finland
Pain in limb
1.7
10.5
295
2031
M84.0
ICD-10 Finland
Malunion of fracture
+∞
10.4
10
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.0
10.4
791
7140
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.3
186
1116
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
5.9
10.0
27
47
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
9.7
143
800
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
9.6
220
1421
ZXA05
NOMESCO Finland
Left side
1.8
9.5
198
1244
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
101.0
9.4
10
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
+∞
9.4
9
*
M84.1
ICD-10 Finland
Nonunion of fracture [pseudarthrosis]
+∞
9.4
9
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.0
9.3
29
60
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.1
9.3
50
168
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
9.3
211
1360
A02BC03
ATC
lansoprazole; oral
1.7
9.2
230
1522
M81.8
ICD-10 Finland
Other osteoporosis
37.1
9.0
11
*
M80
ICD-10 Finland
Osteoporosis with pathological fracture
24.3
8.9
12
5
M03BX02
ATC
tizanidine; oral
1.5
8.9
524
4289
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
8.9
76
336
X58
ICD-10 Finland
Exposure to other specified factors
2.0
8.8
121
657
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
8.8
81
372
M01AH02
ATC
rofecoxib; oral
2.0
8.7
109
573
M01AE02
ATC
naproxen; oral, rectal
1.5
8.6
484
3907
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.5
8.6
65
269
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
8.6
38
111
NHR99
NOMESCO Finland
Other operation for tumour of ankle or foot
90.8
8.4
9
*
J01AA02
ATC
doxycycline; systemic
1.6
8.4
630
5411
M84.3
ICD-10 Finland
Stress fracture, not elsewhere classified
12.9
8.4
14
11
M85.2
ICD-10 Finland
Hyperostosis of skull
+∞
8.3
8
*
M85.1
ICD-10 Finland
Skeletal fluorosis
+∞
8.3
8
*
Q78.1
ICD-10 Finland
Polyostotic fibrous dysplasia
+∞
8.3
8
*
M92.6
ICD-10 Finland
Juvenile osteochondrosis of tarsus
+∞
8.3
8
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
8.3
57
224
S18
ICPC
Laceration/cut
1.6
8.3
312
2288
NF1AA
NOMESCO Finland
Hip X-ray examination
2.5
8.2
63
264
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.7
8.1
183
1170
T82
ICPC
Obesity
3.3
8.0
38
117
H02AB06
ATC
prednisolone; systemic
1.5
8.0
355
2700
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
8.0
97
500
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
7.9
63
267
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.1
7.8
29
73
M02AA07
ATC
piroxicam; topical
1.6
7.7
269
1929
J01FF01
ATC
clindamycin; systemic
1.6
7.7
220
1502
P01BA02
ATC
hydroxychloroquine; oral
2.3
7.5
67
302
R01AD09
ATC
mometasone; nasal
1.5
7.5
374
2908
L03
ICPC
Low back symptom/complaint
1.6
7.4
201
1351
M89.0
ICD-10 Finland
Algoneurodystrophy
80.7
7.4
8
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
6.0
7.4
19
32
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
7.3
80
397
UJF32
NOMESCO Finland
Coloscopy
1.6
7.3
191
1270
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
7.3
86
441
M79.7
ICD-10 Finland
Fibromyalgia
3.1
7.3
38
127
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.1
7.1
37
123
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.8
7.1
45
168
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.8
7.1
125
743
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
4.2
7.0
25
61
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
7.0
213
1476
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.0
7.0
90
479
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
3.3
6.8
32
99
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
6.8
6.8
16
24
WX320
NOMESCO Finland
Spinalanesthesy
1.6
6.7
167
1095
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
6.7
155
994
EDA10
NOMESCO Finland
Biopsy of mandible
22.7
6.7
9
*
NF3AA
NOMESCO Finland
Femur X-ray examination
4.6
6.6
21
46
L11
ICPC
Wrist symptom/complaint
2.1
6.5
68
333
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.5
315
2415
WX110
NOMESCO Finland
Local anesthesy
1.5
6.5
584
5049
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.5
317
2437
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
14.4
6.4
10
7
M25.8
ICD-10 Finland
Other specified joint disorders
14.4
6.4
10
7
J01DA01
ATC
[U] cefalexin; systemic
1.4
6.3
507
4278
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
5.2
6.3
18
35
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.5
6.3
48
201
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
6.3
48
201
NHG22
NOMESCO Finland
Fusion of subtalar joint
11.1
6.3
11
10
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
9.3
6.3
12
13
M87.0
ICD-10 Finland
Idiopathic aseptic necrosis of bone
+∞
6.3
6
*
NBK10
NOMESCO Finland
Partial or total excision of bone of shoulder or upper arm, humerus
+∞
6.3
6
*
M93.2
ICD-10 Finland
Osteochondritis dissecans
+∞
6.3
6
*
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.9
6.2
93
523
L88
ICPC
Rheumatoid/seropositive arthritis
2.9
6.2
35
122
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
4.3
6.1
21
50
WX212
NOMESCO Finland
Femoral plexus blockade
4.7
6.1
19
41
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
4.1
6.1
22
55
J01FA10
ATC
azithromycin; systemic
1.4
6.1
497
4191
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.7
6.1
143
922
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.1
399
3234
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.0
6.1
79
422
R51.80
ICD-10 Finland
Headache
1.7
6.1
129
811
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
6.1
55
253
A07AA02
ATC
nystatin; oral
2.3
6.0
50
221
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
3.8
6.0
23
61

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
34
14
25.12
47.94
2.4
1.9
ug/l
84.2
57.0
0.66
34
14
(3013707) Erythrocyte sedimentation rate by Westergren method
729
5827
1.96
18.85
5.0
3.8
mm/h
11.4
10.7
0.62
681
5398
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
497
3526
1.83
18.81
7.6
6.1
mmol/l
1.2
1.2
1.68
431
2981
(3003458) Phosphate [Moles/volume] in Serum or Plasma
174
873
2.21
18.09
5.4
5.3
mmol/l
1.1
1.0
0.59
160
814
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
441
3167
1.71
14.82
6.4
5.5
mmol/l
1.2
1.2
0.84
405
2879
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
719
5962
1.76
13.64
8.0
7.0
u/l
75.4
76.5
0.32
686
5590
(3013826) Glucose [Moles/volume] in Serum or Plasma
557
4350
1.64
12.90
4.7
4.4
mmol/l
6.5
6.6
1.03
515
4015
(3024561) Albumin [Mass/volume] in Serum or Plasma
417
3052
1.63
12.36
5.1
4.5
g/l
36.5
36.3
0.38
381
2859
(3019550) Sodium [Moles/volume] in Serum or Plasma
907
8222
2.29
11.62
16.4
12.9
mmol/l
139.8
139.7
1.59
897
7990
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
223
1401
1.76
11.62
1.4
1.3
iu/ml
30.7
28.4
0.10
67
441
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
902
8184
2.20
11.10
15.8
11.6
mg/l
18.8
21.9
2.08
730
6346
(3023103) Potassium [Moles/volume] in Serum or Plasma
906
8251
2.21
10.77
16.6
13.0
mmol/l
3.9
3.9
0.08
895
8001
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
212
1347
1.73
10.51
1.4
1.3
u/ml
13.0
10.1
0.21
82
537
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
742
6377
1.66
10.48
4.6
3.9
pmol/l
14.7
14.6
0.24
681
5853
(3032080) INR in Blood by Coagulation assay
372
2750
1.57
10.00
7.3
7.3
inr
1.1
1.2
0.38
106
850
(3015377) Calcium [Moles/volume] in Serum or Plasma
335
2423
1.58
9.88
3.2
3.2
mmol/l
2.3
2.4
1.29
301
2153
(3004588) Protein electrophoresis panel - Serum or Plasma
83
394
2.21
9.74
2.1
2.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
177
1092
1.76
9.68
2.7
2.4
ug/g
120.5
117.1
0.05
144
869
(3013650) Neutrophils [#/volume] in Blood by Automated count
563
4587
1.53
9.55
8.1
8.7
e9/l
4.2
4.0
1.06
501
4010
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
420
3220
1.53
9.43
3.3
2.2
nmol/l
78.2
75.2
1.46
387
2915
(3037467) Urinalysis macro (dipstick) panel - Urine
649
5468
1.55
9.32
5.3
3.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
511
4098
1.51
9.20
6.6
6.0
e9/l
0.2
0.2
1.55
453
3632
(3036481) Cortisol [Moles/volume] in Serum or Plasma
126
714
1.88
9.08
2.6
2.0
nmol/l
361.5
374.9
0.31
112
659
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
486
3865
1.51
9.06
5.7
5.9
umol/l
9.8
10.9
1.98
460
3646
(3001604) Monocytes [#/volume] in Blood
493
3943
1.50
8.87
6.4
5.6
e9/l
0.6
0.6
1.17
436
3435
(3020630) Protein [Mass/volume] in Serum or Plasma
94
486
2.03
8.85
2.0
2.8
g/l
68.3
67.2
0.80
83
449
(3019198) Lymphocytes [#/volume] in Blood
505
4066
1.50
8.75
6.5
5.6
e9/l
2.1
1.9
0.36
453
3609
(3006315) Basophils [#/volume] in Blood
494
3960
1.50
8.74
6.5
5.6
e9/l
0.0
0.0
1.47
438
3454
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
321
2352
1.54
8.72
3.0
2.4
u/l
52.7
57.1
1.92
296
2181
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
95
497
2.01
8.66
3.7
3.7
ng/l
75.1
80.8
0.24
81
449
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
836
7540
1.71
8.43
5.6
4.6
mu/l
1.7
2.0
1.24
776
6973
(42870588) Differential panel, method unspecified - Blood
340
2549
1.51
8.20
6.4
5.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
461
3703
1.46
7.74
4.3
3.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
256
1826
1.54
7.71
2.3
2.1
mg/l
2.8
3.0
0.56
215
1570
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
271
1962
1.53
7.61
1.4
1.3
u/ml
0.8
1.8
1.96
83
523
(3006504) Eosinophils/100 leukocytes in Blood
460
3704
1.45
7.57
6.6
5.7
%
2.9
2.8
0.35
424
3452
(3019225) pH of Specimen
118
693
1.80
7.57
4.9
3.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
472
3834
1.44
7.33
6.8
5.8
%
28.7
28.9
0.12
438
3585
(3018010) Neutrophils/100 leukocytes in Blood
467
3791
1.44
7.25
6.5
5.5
%
56.6
56.6
0.00
436
3560
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
351
2703
1.46
7.20
3.5
3.1
ng/l
44.9
37.5
0.22
219
1695
(3019069) Monocytes/100 leukocytes in Blood
459
3725
1.43
7.08
7.0
5.9
%
8.4
8.4
0.08
428
3499
(3004789) Transferrin [Mass/volume] in Serum or Plasma
156
1011
1.65
7.00
2.5
2.2
g/l
2.4
2.4
0.15
147
935
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
33
119
2.83
6.96
3.9
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
178
1198
1.59
6.84
2.0
1.7
nmol/l
1072.6
1188.7
1.12
132
913
(3018418) pH of Serum or Plasma
279
2079
1.48
6.69
4.3
3.7
ph
7.4
7.4
3.16
59
390
(40768804) Tissue Pathology biopsy report
397
3164
1.43
6.64
2.1
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
441
3583
1.42
6.62
6.8
5.7
%
0.7
0.7
0.07
411
3348
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
382
3028
1.43
6.57
3.6
3.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
166
1110
1.60
6.54
1.5
1.3
titre
358.0
519.7
1.42
40
238
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
282
2118
1.46
6.46
2.2
2.0
u/l
138.0
214.6
1.55
263
1990
(3009261) Glucose [Presence] in Urine by Test strip
477
3950
1.40
6.31
3.8
3.2
estimate
0.0
0.0
0.80
88
717
(3035350) Ketones [Presence] in Urine by Test strip
469
3881
1.40
6.19
3.7
3.2
estimate
0.0
0.0
0.00
88
734
(3026493) Urate [Moles/volume] in Serum or Plasma
253
1875
1.47
6.17
2.5
2.5
umol/l
2942.9
5290.7
0.57
216
1643
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
143
940
1.61
6.03
2.6
2.3
%
22.9
23.8
0.38
119
807
(3007930) Methemoglobin/Hemoglobin.total in Blood
52
251
2.13
5.92
5.7
7.5
%
0.9
0.9
0.07
52
235
(40768797) Stomach Pathology biopsy report
153
1029
1.58
5.86
1.4
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
52
253
2.11
5.81
5.7
7.4
%
1.6
1.5
0.22
52
236
(3022948) Iron [Moles/volume] in Serum or Plasma
160
1106
1.53
5.42
2.6
2.3
umol/l
13.5
13.8
0.26
154
1020
(3010813) Leukocytes [#/volume] in Blood
963
9280
2.62
5.30
22.7
17.4
e9/l
6.7
6.6
0.46
948
9030
(3021601) Nitrite [Presence] in Urine by Test strip
464
3901
1.36
5.25
5.1
4.4
estimate
0.0
0.0
0.50
89
752
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
920
8731
1.80
5.16
11.6
9.3
u/l
25.8
26.6
0.70
900
8448
(3009214) Lutropin [Units/volume] in Serum or Plasma
53
274
1.99
5.06
1.6
1.4
u/l
9.4
9.4
0.01
46
223
(3026008) Bacteria identified in Urine by Culture
282
2200
1.39
5.05
3.3
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
30
123
2.48
5.00
2.0
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
961
9278
2.41
4.79
22.7
17.3
e12/l
4.5
4.5
0.71
944
9033
(3022217) INR in Platelet poor plasma by Coagulation assay
118
783
1.58
4.78
21.2
18.5
inr
1.1
1.2
0.40
24
121
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
20
5.04
4.78
1.6
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
837
7793
1.49
4.78
4.6
4.1
mmol/l
5.8
5.8
0.59
776
7154
(3005719) IgG [Mass/volume] in Serum or Plasma
95
598
1.65
4.77
2.4
2.6
g/l
10.0
10.7
1.02
88
542
(3021788) Differential panel - Synovial fluid
29
120
2.46
4.75
1.4
1.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
961
9282
2.39
4.72
22.8
17.4
g/l
135.9
136.3
0.39
956
9157
(3041096) Erythrocytes [Presence] in Urine by Automated
279
2196
1.38
4.69
3.5
2.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
960
9272
2.34
4.65
22.7
17.3
e9/l
261.2
254.8
2.25
945
9051
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
15
43
3.53
4.62
1.7
1.5
u/l
3.9
4.9
—
7
20
(3013512) EKG study
263
2057
1.38
4.58
3.9
3.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
81
2.76
4.53
1.5
1.5
%
33.1
65.8
4.71
15
54
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
29
123
2.40
4.52
1.7
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
786
7253
1.41
4.52
5.8
5.1
mmol/mol
38.4
39.1
1.57
741
6770
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
51
272
1.92
4.48
2.4
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
107
707
1.58
4.42
4.9
4.6
u/l
225.3
255.2
1.37
95
669
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
25
100
2.54
4.40
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
352
2895
1.34
4.40
2.2
1.9
pmol/l
101.4
96.0
1.21
199
1491
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
231
1779
1.39
4.40
2.0
1.8
mg/l
0.7
1.1
3.47
170
1327
(40760888) Immunoglobulin light chains.free panel - Serum
29
125
2.36
4.37
2.5
4.5
—
—
—
0
0
(3039000) Anion gap in Blood
31
140
2.25
4.22
6.5
11.2
mmol/l
12.3
11.1
1.47
31
127
(3018572) Chloride [Moles/volume] in Blood
31
140
2.25
4.22
6.5
11.2
mmol/l
105.1
105.2
0.04
31
127
(3026389) Candida sp identified in Specimen by Organism specific culture
24
97
2.51
4.15
1.5
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
91
588
1.60
4.14
6.8
9.1
g/l
127.5
120.8
2.44
91
570
(3022145) Colonoscopy Study observation
122
844
1.51
4.11
1.4
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
260
1.89
4.05
2.4
1.9
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
222
1721
1.37
4.03
4.0
3.4
kg/l
1.0
1.0
0.16
50
233
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
57
327
1.79
4.02
8.2
11.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
77
481
1.65
4.01
2.4
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
104
700
1.54
3.98
6.2
8.2
mmol/l
0.9
1.1
0.18
80
557
(3016502) Oxygen saturation in Arterial blood
94
620
1.57
3.93
6.1
8.8
%
96.6
95.7
1.10
89
602
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
263
1.87
3.92
1.5
1.6
iu/ml
0.0
0.0
—
7
50
(40761511) CBC panel - Blood by Automated count
908
8673
1.59
3.84
15.2
11.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
297
2423
1.32
3.83
2.4
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
621
5590
1.30
3.79
3.3
2.9
u/l
42.9
43.2
0.03
585
5263
(3021447) Carbon dioxide [Partial pressure] in Venous blood
91
601
1.57
3.79
3.6
3.5
kpa
5.8
5.8
0.21
86
582
(3002032) Base excess in Venous blood by calculation
90
593
1.57
3.79
3.7
3.5
mmol/l
1.6
2.0
0.61
69
471
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
66
2.76
3.77
1.2
1.1
u/l
58.9
52.3
0.20
13
46
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
55
2.94
3.75
1.1
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
126
896
1.47
3.71
6.2
5.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
123
874
1.47
3.64
1.7
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
33
163
2.06
3.63
2.3
4.1
mg/l
33.5
87.7
0.77
23
130
(3026782) Osmolality of Urine
186
1424
1.38
3.63
2.9
2.4
mosm/kgh2o
528.3
550.1
0.62
156
1219
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
45
249
1.85
3.59
2.1
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
7
9
7.82
3.56
1.6
1.1
umol/l
15.4
17.6
—
7
9
(3012095) Magnesium [Moles/volume] in Serum or Plasma
152
1130
1.41
3.52
3.6
3.2
mmol/l
0.8
0.8
0.74
137
1067
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
231
1837
1.34
3.52
2.4
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
36
186
1.97
3.52
1.4
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
13
6.19
3.50
2.6
2.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
180
1.98
3.47
1.8
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
194
1506
1.36
3.46
1.7
1.6
pmol/l
106358810.5
30174208.6
0.64
173
1266
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
44
245
1.83
3.45
1.3
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
102
706
1.50
3.44
6.5
8.1
kpa
5.1
5.1
0.02
96
680
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
146
1083
1.41
3.43
2.2
1.8
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
42
232
1.85
3.38
1.5
1.6
—
215.0
—
0
8
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
32
161
2.02
3.37
2.3
4.1
ratio
1.4
2.2
—
5
15
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
41
225
1.86
3.37
1.3
1.2
u/ml
11.4
9.9
—
9
37
(3007164) IgA [Mass/volume] in Serum or Plasma
216
1711
1.34
3.37
1.5
1.4
g/l
2.2
2.3
0.54
138
1061
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
646
5888
1.28
3.36
3.4
3.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
82
547
1.54
3.29
2.5
2.2
nmol/l
11.1
13.1
1.50
72
496
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
850
8056
1.40
3.29
4.4
4.0
mmol/l
4.7
4.7
0.91
805
7525
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
163
2.00
3.27
2.4
4.1
mg/l
20.8
33.0
2.03
22
131
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
78
516
1.56
3.25
3.8
3.3
pmol/l
4.5
4.6
0.56
67
459
(3042936) Bacteria identified in Isolate by Culture
137
1016
1.40
3.22
2.1
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
315
2642
1.28
3.21
3.1
3.1
u/l
28.7
31.4
1.26
307
2524
(3001122) Ferritin [Mass/volume] in Serum or Plasma
422
3673
1.26
3.16
3.3
2.7
ug/l
104.0
110.0
0.28
389
3415
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
223
1.83
3.15
1.6
1.4
ug/g
252.6
296.6
0.64
23
134
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
125
917
1.42
3.13
4.2
4.1
%
32.7
31.9
0.41
92
623
(3027801) Oxygen [Partial pressure] in Arterial blood
100
706
1.46
3.08
6.6
8.1
kpa
12.7
12.5
0.14
93
682
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
175
1.92
3.03
1.8
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
202
1613
1.32
2.96
1.6
1.5
nmol/l
23.2
21.2
0.96
180
1367
(3004616) Nuclear Ab [Presence] in Serum
20
88
2.30
2.95
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
844
8023
1.36
2.92
4.3
4.0
mmol/l
1.5
1.5
0.01
797
7463
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
858
8180
1.38
2.88
4.8
4.4
mmol/l
2.8
2.8
0.85
805
7595
(3032057) Clostridioides difficile [Presence] in Stool
7
13
5.41
2.87
2.7
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
221
1795
1.30
2.86
4.4
3.9
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
96
684
1.45
2.83
1.9
3.0
%
1.8
1.8
0.21
83
611
(3022621) pH of Urine by Test strip
73
493
1.52
2.80
4.9
2.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
78
535
1.50
2.79
2.3
2.5
e9/l
5.5
3.9
0.70
64
429
(3023520) Reticulocytes [#/volume] in Blood
73
494
1.52
2.78
2.3
3.1
e9/l
72.3
73.2
0.06
59
364
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
58
374
1.59
2.73
1.6
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
15
60
2.52
2.71
1.3
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
60
2.52
2.71
1.3
1.3
g/l
2.7
2.5
—
10
41
(3027135) IgG subclass 1 [Mass/volume] in Serum
15
60
2.52
2.71
1.3
1.3
g/l
6.8
6.6
—
10
42
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
60
2.52
2.71
1.3
1.3
g/l
0.4
0.3
—
9
41
(3025159) Blasts/100 leukocytes in Blood
82
572
1.47
2.70
4.7
4.4
%
0.0
0.2
1.27
20
133
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
49
2.68
2.63
1.5
1.4
%
33.7
29.5
—
7
34
(3003338) MCHC [Mass/volume]
765
7204
1.28
2.61
18.1
15.0
g/l
332.9
333.0
0.07
760
7154
(3000850) Epithelial cells [#/volume] in Urine
189
1522
1.30
2.60
2.7
2.3
e6/l
5.7
7.1
0.64
164
1329
(3029937) Albumin [Presence] in Urine by Test strip
250
2088
1.26
2.57
4.1
3.5
estimate
0.0
0.0
1.28
86
734
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
161
1271
1.32
2.56
2.9
2.7
mmol/l
2.4
2.4
0.94
143
1124
(3028026) IgM [Mass/volume] in Serum or Plasma
69
472
1.50
2.52
1.6
1.6
g/l
1.8
1.5
0.23
64
433
(36660697) Celiac disease serology panel - Serum
93
676
1.41
2.48
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
40
241
1.69
2.48
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
559
1.45
2.44
4.7
3.2
mmol/l
1.2
1.2
0.14
74
478
(3002179) Metamyelocytes/100 leukocytes in Blood
81
576
1.44
2.44
4.6
4.1
%
0.4
0.5
0.31
20
125
(3019060) Gas panel - Arterial blood
60
402
1.52
2.42
5.0
6.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
76
535
1.46
2.42
6.2
7.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
45
282
1.62
2.41
1.7
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
58
2.43
2.37
1.6
2.3
u/field
5.0
2.3
—
5
28
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
806
7668
1.28
2.34
13.4
10.5
ml/min/173m2
86.4
86.1
0.15
669
6206
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
133
1.90
2.33
1.2
1.2
u/ml
1.4
4.2
—
7
43
(4094501)
34
200
1.73
2.31
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
39
240
1.65
2.25
1.8
3.5
g/l
0.3
0.3
0.02
16
101
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
215
1795
1.25
2.20
3.6
2.8
ng/l
1046.4
1004.5
0.09
173
1495
(3035637) Corticotropin [Mass/volume] in Plasma
17
80
2.14
2.19
1.7
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
36
219
1.67
2.18
1.1
1.2
titre
192.0
84.8
—
5
21
(3024980) IgG subclass 4 [Mass/volume] in Serum
21
108
1.96
2.16
1.6
1.9
g/l
0.5
0.8
0.79
16
81
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
137
1.85
2.15
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
140
1112
1.30
2.14
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
809
7725
1.26
2.11
3.9
3.6
mmol/l
1.3
1.3
0.09
762
7159
(3044941) Cell count panel - Synovial fluid
21
109
1.95
2.11
1.3
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
49
2.47
2.11
1.0
1.1
u/l
1.0
1.1
—
7
27
(3018095) Leukocytes [#/volume] in Urine
303
2637
1.22
2.09
3.9
3.3
e6/l
99.4
84.6
0.16
223
1802
(3017181) Myelocytes/100 leukocytes in Blood
85
629
1.38
2.08
4.7
4.3
%
0.5
0.9
1.55
22
170
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
17
82
2.09
2.07
8.6
6.3
mg/l
11.8
11.1
0.29
17
76
(3023323) Follitropin [Units/volume] in Serum or Plasma
63
442
1.45
2.07
1.6
1.4
iu/l
28.8
25.5
0.34
55
377
(3021440) Promyelocytes/100 leukocytes in Blood
81
596
1.39
2.05
4.9
4.3
%
0.0
0.1
3.74
20
152
(3044889) 12 lead EKG panel
583
5400
1.19
2.02
3.7
3.3
—
—
—
0
0
(4062490)
14
63
2.24
2.01
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
119
1.87
1.98
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
161
1316
1.27
1.97
4.4
3.5
ng/l
194.6
350.9
0.74
116
929
(3015171) Extractable nuclear Ab [Units/volume] in Serum
47
314
1.52
1.96
1.3
1.2
u/ml
2.9
1.2
—
5
28
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
130
1036
1.29
1.95
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
172
1.71
1.95
1.9
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
16
3.77
1.93
1.0
1.9
umol/l
7.2
17.8
—
6
16
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
33
2.74
1.93
1.6
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
254
2188
1.22
1.93
3.3
2.9
e6/l
151.4
56.9
0.35
207
1660
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
135
1.80
1.92
1.2
1.3
u/ml
2.8
5.4
—
8
59
(3011412) CD3 cells [#/volume] in Blood
14
65
2.17
1.88
2.4
2.2
e9/l
0.6
1.2
—
8
37
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
22
3.20
1.88
1.1
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
52
2.32
1.88
1.8
2.3
—
2.2
—
0
6
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
107
1.89
1.87
2.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
107
1.89
1.87
2.0
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
182
1.67
1.87
1.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
28
2.87
1.86
1.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
108
1.87
1.82
2.0
1.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
12
4.18
1.82
1.2
1.8
mmol/l
1.2
1.2
—
5
12
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
126
1010
1.28
1.81
1.7
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
53
2.28
1.81
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
45
304
1.50
1.81
1.5
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
266
2316
1.20
1.80
4.0
3.1
mmol/l
7.6
7.9
0.67
239
1958
(3006462) Nitrate [Presence] in Urine
9
35
2.59
1.80
3.9
3.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
60
430
1.42
1.79
4.3
3.4
kpa
5.0
5.2
0.85
54
405
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
36
232
1.57
1.78
2.0
2.1
ug/l
0.4
2.8
1.26
29
212
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
109
1.85
1.78
2.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
275
3120
0.84
1.77
2.8
2.6
—
—
—
0
0
(4211845)
10
41
2.45
1.76
3.5
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
57
407
1.43
1.74
4.4
3.4
mmol/l
1.2
1.8
0.75
43
303
(3009343) pH of Capillary blood
59
424
1.42
1.74
4.3
3.4
ph
7.4
7.4
—
10
54
(3017704) Immunofixation for Urine
9
36
2.51
1.74
2.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
110
1.84
1.74
2.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
110
1.84
1.74
2.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
581
1.35
1.71
2.4
2.5
ml/min/173m2
63.3
69.9
0.66
31
235
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
172
1.65
1.68
1.2
1.3
u/ml
153.8
234.9
1.79
14
99
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
180
1.63
1.68
2.8
2.8
u/ml
0.3
0.4
0.39
15
103
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
228
1.55
1.67
1.6
2.2
g/l
3.6
3.7
0.38
19
167
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
33
212
1.58
1.67
3.7
2.1
mg/l
11.3
11.0
0.09
33
199
(3008898) HLA-B27 [Presence]
50
352
1.44
1.66
1.1
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
17
90
1.90
1.66
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
25
2.81
1.65
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
25
2.81
1.65
1.3
1.1
—
—
—
0
0
(4306422)
22
127
1.75
1.65
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
76
1.99
1.65
1.1
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
14
3.58
1.61
1.2
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
14
3.58
1.61
3.0
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
1.0
1.6
—
—
—
0
0
(4027681)
11
50
2.21
1.57
1.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
476
1.37
1.57
1.1
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
49
348
1.43
1.56
2.3
2.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
71
538
1.34
1.55
2.5
2.3
ug/l
6.8
7.5
0.17
53
483
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
57
2.12
1.55
1.6
1.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
44
2.29
1.53
1.5
1.6
u/field
2.0
1.9
—
5
33
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
85
663
1.31
1.53
2.3
2.2
g/l
0.2
0.2
0.13
77
625
(3000475) Leukocytes [#/volume] in Synovial fluid
28
177
1.60
1.53
1.6
1.7
e6/l
1059.4
13862.7
3.37
19
138
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
131
1.69
1.50
1.1
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
210
1.54
1.50
1.6
2.2
g/l
9.5
10.4
0.64
25
186
(3000492) Spirometry study
102
819
1.27
1.48
1.3
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
17
292
0.57
1.48
1.2
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
117
1.72
1.45
1.6
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
228
1.51
1.45
1.6
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
228
1.51
1.45
1.6
2.2
g/l
6.7
7.5
1.30
22
178
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
28
2.51
1.45
1.1
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
76
589
1.31
1.44
3.2
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
14
73
1.93
1.44
1.7
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
57
425
1.36
1.40
2.7
2.3
u/l
1255.3
4441.1
1.90
22
185
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
27
174
1.57
1.38
3.5
2.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
461
1.34
1.38
1.2
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
256
1.46
1.38
1.3
2.4
g/l
1.5
1.4
0.33
29
225
(3009871) Measles virus Ab [Titer] in Serum
6
23
2.62
1.37
2.0
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
22
135
1.64
1.36
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
42
299
1.42
1.35
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
227
1998
1.18
1.35
3.4
2.8
e6/l
0.2
0.5
2.16
179
1474
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
24
2.51
1.30
2.2
2.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
185
1.53
1.30
1.5
1.2
—
—
—
0
0
(4268621)
16
91
1.77
1.29
2.1
2.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
34
2.36
1.29
1.1
1.0
u/l
75.8
97.7
—
8
24
(3021879) Hepatitis B virus core Ab [Presence] in Serum
89
717
1.27
1.28
1.3
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
55
2.01
1.27
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
224
1979
1.17
1.27
3.4
2.7
—
—
—
0
0
(3000012) Reticulocyte production index
8
35
2.30
1.27
1.4
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
42
304
1.40
1.25
4.7
3.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
204
1791
1.18
1.25
3.6
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
21
131
1.62
1.24
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
21
131
1.62
1.24
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
212
1.48
1.24
1.5
2.2
g/l
2.8
3.1
1.32
22
171
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
147
1.58
1.24
4.6
5.8
iu/ml
677.6
337.1
—
5
20
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
45
2.01
1.23
1.4
2.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
40
288
1.41
1.23
2.7
3.0
%
46.5
48.3
0.15
40
283
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
29
196
1.49
1.23
1.6
2.4
g/l
0.7
0.9
0.14
24
179
(4034850)
35
246
1.44
1.22
6.5
8.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
803
7773
1.18
1.22
16.2
12.5
%
39.8
40.3
0.88
601
5939
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
37
2.17
1.21
1.9
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
70
879
0.78
1.21
1.6
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
34
239
1.44
1.19
1.5
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
38
2.11
1.18
3.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
38
2.11
1.18
3.3
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
38
2.11
1.18
3.1
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
38
2.11
1.18
3.3
1.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
38
2.11
1.18
3.4
1.9
e9/l
0.2
0.2
—
8
38
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
50
2.01
1.16
1.2
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
72
1.82
1.15
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
72
1.82
1.15
1.5
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
20
2.51
1.15
2.2
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
36
0.00
1.14
0.0
4.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
30
208
1.46
1.14
1.4
1.4
pmol/l
66.2
233.8
1.35
30
203
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
657
1.25
1.12
1.1
1.2
iu/ml
73.9
138.3
2.48
30
265
(3014271) Vancomycin [Susceptibility]
7
30
2.34
1.12
3.3
2.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
31
2.27
1.10
2.4
2.1
—
—
—
0
0
(1002224) Polysomnography panel
50
382
1.33
1.09
1.1
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
70
561
1.27
1.08
10.1
6.9
mmol/l
8.4
8.8
0.22
64
535
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
74
1.77
1.07
2.8
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
32
229
1.41
1.04
1.1
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
46
597
0.76
1.04
1.3
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
99
829
1.22
1.04
2.0
2.8
umol/l
5.2
7.8
2.11
87
713
(3029396) Erythrocyte agglutination [Presence] in Blood
5
22
2.28
1.03
5.0
3.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
107
904
1.21
1.03
1.7
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
34
2.07
1.03
1.3
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
137
1185
1.18
1.02
2.8
2.5
e6/l
1.0
1.0
0.08
82
647
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
83
1.70
1.01
2.6
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
66
530
1.26
1.01
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
68
1.77
1.00
2.4
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
130
1121
1.18
1.00
3.0
2.7
e6/l
3.4
3.1
0.15
77
582
(3002256) Pathology report gross observation
115
981
1.20
1.00
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
2.0
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
35
2.01
1.00
2.0
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
35
2.01
1.00
2.4
2.1
ug/l
24.0
248.2
—
7
30
(3023419) Bacteria identified in Sputum by Culture
13
76
1.72
0.99
2.0
2.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
173
1.46
0.98
2.5
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
23
2.18
0.98
4.2
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
23
2.18
0.98
16.2
13.1
—
—
—
0
0
(4010399)
65
525
1.25
0.96
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
51
1.77
0.94
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
51
1.77
0.94
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
62
1.78
0.94
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
37
1.90
0.94
2.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
37
1.90
0.94
2.1
2.8
u/ml
898.3
778.4
—
7
37
(3021901) Oxygen saturation in Capillary blood
18
117
1.55
0.94
2.7
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
175
1.44
0.93
1.5
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
27
2.23
0.93
1.8
2.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
3.8
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
3.8
1.9
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
12
70
1.72
0.93
1.5
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
134
1.50
0.92
2.3
2.2
%
16.8
16.4
0.15
13
67
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
267
0.67
0.91
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
141
1235
1.17
0.91
2.0
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
28
2.15
0.91
4.2
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
28
2.15
0.91
2.3
2.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
219
0.63
0.91
1.1
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
143
1.48
0.90
4.3
2.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
29
2.08
0.89
1.2
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
39
298
1.32
0.89
2.2
2.7
%
0.7
0.7
0.49
39
288
(3048929) Epstein Barr virus Ab [Presence] in Serum
41
316
1.31
0.88
1.2
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
43
1.87
0.87
8.0
7.2
—
—
—
0
0
(3036489) Thrombin time
39
299
1.32
0.87
2.0
2.1
s
20.0
20.9
1.25
26
268
(3033658) Prothrombin time (PT) actual/Normal
208
1881
1.13
0.87
4.2
3.6
%
95.0
93.5
0.35
199
1830
(3051611) Lipemic interference index of Serum or Plasma
11
64
1.73
0.86
2.9
2.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
262
0.68
0.84
1.6
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
25
179
1.41
0.84
1.6
2.2
g/l
38.5
38.2
0.06
18
160
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
174
1559
1.14
0.84
1.5
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
21
146
1.45
0.83
3.4
3.3
mmol/l
2.3
2.6
0.31
14
96
(3005033) Fetal Nuchal fold Thickness US
18
260
0.69
0.82
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
18
259
0.69
0.80
1.8
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
704
1.20
0.80
2.7
2.3
u/l
34.4
104.1
0.51
75
594
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
123
1079
1.16
0.80
1.9
1.8
%
1.4
1.4
0.01
107
970
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
88
752
1.19
0.79
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
87
744
1.19
0.77
2.0
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
20
140
1.44
0.77
2.4
3.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
342
1.27
0.76
3.4
2.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
197
1792
1.12
0.75
5.3
4.5
ug/l
1.9
2.5
0.92
181
1620
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
324
0.73
0.75
1.5
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
53
1.70
0.75
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
323
0.74
0.74
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
55
1.64
0.73
2.7
4.3
%
11.2
11.5
—
9
55
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
322
0.74
0.73
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
322
0.74
0.73
1.5
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
39
1.80
0.72
1.1
1.1
iu/ml
115.2
174.1
—
7
39
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
17
117
1.46
0.72
1.4
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
49
399
1.24
0.72
6.2
7.0
mmol/l
24.8
24.9
0.05
49
394
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
33
256
1.30
0.71
2.1
2.2
%
99.1
92.4
1.04
26
239
(40768446) Kidney Pathology biopsy report
5
26
1.93
0.70
1.6
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
91
789
1.17
0.70
2.2
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
310
1.27
0.70
1.7
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
2.6
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
2.6
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
69
1.60
0.68
2.6
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
59
1.53
0.68
1.3
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
47
384
1.24
0.68
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
205
1883
1.11
0.67
5.2
4.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
228
2109
1.11
0.65
1.8
1.7
mmol/l
1.4
1.4
0.28
205
1784
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
154
1.37
0.65
3.6
3.8
%
58.8
56.8
0.21
21
154
(4146454)
11
70
1.58
0.65
2.0
2.9
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
62
1.62
0.65
1.0
1.0
mg/l
274.8
293.6
—
10
54
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
62
1.62
0.65
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
347
0.77
0.63
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
59
695
0.84
0.63
3.9
3.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
130
1.39
0.61
1.1
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.8
—
2.0
—
0
10
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
148
1.36
0.60
3.4
3.6
e9/l
4.0
4.2
0.16
20
148
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
51
605
0.83
0.59
1.3
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
11
72
1.53
0.59
3.5
3.2
u/ml
18.5
74.7
1.33
11
72
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
162
0.68
0.59
2.6
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
53
1.51
0.58
1.1
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
35
1.72
0.57
3.7
1.4
nmol/l
122.8
159.8
—
6
35
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
37
304
1.23
0.53
1.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
195
1810
1.10
0.53
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
22
169
1.31
0.53
2.7
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
2.7
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
96
0.62
0.52
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
149
1368
1.11
0.51
2.1
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
172
1591
1.10
0.51
1.7
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
229
2147
1.09
0.50
4.4
4.0
mg/mmol
7.6
8.8
0.23
154
1336
(3045788) Cell count panel - Pleural fluid
6
41
1.47
0.50
1.2
1.2
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
41
1.47
0.50
1.2
1.0
ng/l
383.0
263.3
—
6
25
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
41
1.47
0.50
1.2
1.0
ng/l
31.7
36.5
—
6
23
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
6
41
1.47
0.50
1.2
1.0
ng/l
939.2
633.2
—
6
25
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
76
1.45
0.48
2.7
4.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
717
7022
1.08
0.47
18.2
14.3
%
13.5
13.5
0.10
711
6870
(3051651) Icteric interference index of Serum or Plasma
7
48
1.46
0.47
2.9
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
60
524
1.15
0.46
1.8
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
7
49
1.43
0.46
1.1
1.2
e6/l
1275.4
1519.4
—
7
33
(3032773) Endomysium IgG Ab [Titer] in Serum
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
218
2050
1.08
0.45
3.6
3.3
mg/l
320.9
275.2
0.06
141
1293
(3044290) Cell count panel - Cerebral spinal fluid
19
147
1.30
0.45
1.5
1.5
—
—
—
0
0
(44806118)
12
86
1.40
0.44
2.2
1.6
—
—
—
0
0
(44790048)
12
86
1.40
0.44
2.2
1.6
—
—
—
0
0
(44790049)
12
86
1.40
0.44
2.2
1.6
—
—
—
0
0
(44790047)
12
86
1.40
0.44
2.2
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
51
1.38
0.44
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
129
0.69
0.43
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
31
1.62
0.43
2.4
4.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
151
0.73
0.43
1.0
1.1
u/ml
0.4
2.6
—
6
60
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
74
663
1.13
0.41
2.9
4.4
ug/l
8.2
16.0
0.54
58
535
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.1
—
—
—
0
0
(4024509)
8
59
1.36
0.41
1.6
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
61
1.31
0.39
1.1
1.2
—
—
—
0
0
(44813793)
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
35
1.43
0.39
1.8
3.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
71
1.41
0.39
1.8
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
52
457
1.15
0.39
3.3
1.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
36
1.39
0.38
1.4
1.1
miu/ml
2380.2
1665.1
—
5
36
(3039443) Prostate specific Ag panel - Serum or Plasma
10
136
0.73
0.38
1.5
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
125
1.28
0.37
2.5
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
70
631
1.12
0.36
2.1
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
52
460
1.14
0.36
3.3
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
11
81
1.36
0.36
6.7
4.5
u/ml
58.0
53.2
—
5
22
(3003888) Timothy IgE Ab [Units/volume] in Serum
12
157
0.76
0.36
1.0
1.1
u/ml
9.7
7.4
—
7
77
(4281824)
5
78
0.64
0.35
1.2
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
41
357
1.15
0.35
3.8
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
18
144
1.25
0.35
1.2
1.0
u/ml
3.7
1.6
—
8
65
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
122
0.74
0.35
1.4
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
156
0.77
0.34
2.3
3.7
mg/l
16.5
26.6
—
6
100
(3021589) Normoblasts [#/volume] in Blood
368
3556
1.06
0.34
10.3
8.5
e9/l
0.0
0.0
0.97
318
2922
(3028308) Erythrocytes [#/volume] in Pleural fluid
6
44
1.37
0.34
1.2
1.2
e6/l
11466.7
60455.4
—
6
23
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
200
1.20
0.34
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
204
1938
1.07
0.34
5.6
6.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
52
463
1.13
0.34
3.3
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
51
454
1.13
0.33
1.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
105
1131
0.92
0.33
1.8
1.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
6
47
1.28
0.32
1.0
1.3
—
17.3
—
0
8
(3052851) Hemolysis interference index of Serum or Plasma
24
202
1.19
0.31
2.4
2.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
156
1.22
0.31
1.8
1.7
—
—
—
0
0
(4035726)
69
629
1.10
0.31
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
54
1.30
0.30
3.7
3.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
346
0.86
0.30
1.6
1.3
miu/ml
249.3
245.4
0.02
14
185
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
111
1.27
0.30
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
152
1437
1.07
0.30
4.6
4.0
%
20.7
21.0
0.10
70
624
(21494755) Public health laboratory ask at order entry panel
93
1000
0.92
0.29
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
7
57
1.23
0.29
2.4
2.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
76
1.32
0.28
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
62
1.29
0.28
1.1
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
215
1.17
0.27
1.2
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
178
1.18
0.26
2.6
2.3
ug/min
80.0
91.0
0.08
15
109
(44816559) Phosphatidylethanol [Mass/volume] in Blood
22
188
1.17
0.25
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
75
1.20
0.25
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
76
1.19
0.24
2.9
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
170
1.18
0.24
4.0
3.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
17
143
1.19
0.23
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
38
1.32
0.23
2.0
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
409
1.11
0.23
1.4
1.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
19
162
1.18
0.23
1.6
1.4
u/ml
133.1
104.1
—
10
34
(3011288) Drugs identified in Urine by Screen method
34
304
1.12
0.23
5.0
2.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
88
1.25
0.22
1.0
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.8
—
1131650.0
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(44806071)
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
45.4
—
0
10
(40757373) Influenza virus identified in Isolate
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(4198724)
5
43
1.16
0.21
2.2
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
335
1.11
0.21
2.1
1.7
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
164
1.16
0.20
1.5
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.1
—
69.7
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
0
14
0.00
0.20
0.0
6.9
—
56.0
—
0
14
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.1
—
48.6
—
0
9
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
49
1.23
0.20
1.8
1.4
ug/l
62.8
6.6
—
6
39
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
114
0.79
0.20
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
231
1.13
0.19
3.1
1.8
iu/l
6.9
5.3
0.29
13
83
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
99
1.21
0.19
1.3
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.5
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
19
165
1.15
0.19
1.5
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
58
1.21
0.18
1.7
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
58
1.21
0.18
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
46
426
1.08
0.17
3.5
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
61
1.15
0.17
1.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
67
0.75
0.17
1.6
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
26
234
1.11
0.16
2.3
2.5
g/l
3.7
3.7
0.02
26
224
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
329
0.91
0.16
1.6
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
120
1.17
0.16
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
1056
0.95
0.16
3.2
2.8
ug/l
0.7
0.7
0.22
63
643
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
139
1.15
0.16
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
71
1.13
0.16
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
92
1.20
0.16
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
92
1.20
0.16
1.2
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
72
1.11
0.16
1.1
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
78
1.16
0.15
2.9
2.4
mmol/l
4.0
4.0
—
9
78
(3035285) Chloride [Moles/volume] in Venous blood
9
78
1.16
0.15
2.9
2.4
mmol/l
106.3
105.8
—
9
78
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
80
1.13
0.15
1.4
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
129
0.85
0.14
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
21
189
1.11
0.14
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
250
0.92
0.11
1.3
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
45
1.11
0.10
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(3020891) Body temperature
27
253
1.07
0.08
4.0
4.6
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
2.4
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
88
1.14
0.08
1.5
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
89
1.12
0.07
1.7
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
105
0.86
0.06
1.2
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
119
1.09
0.06
2.1
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
168
1.07
0.06
2.9
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
243
2452
0.99
0.04
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
75
735
1.02
0.04
3.5
2.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
38
368
1.03
0.04
2.1
1.7
mg/l
1.6
4.3
1.04
27
256
(3049717) Cytology report of Urine Cyto stain
24
231
1.04
0.02
2.9
2.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
40
390
1.03
0.02
1.2
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
195
1936
1.01
0.02
2.0
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
21
203
1.04
0.01
6.1
2.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
11
104
1.06
0.01
1.1
1.8
—
1744.0
—
0
5
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
104
1.06
0.01
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
35
344
1.02
0.00
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
50
494
1.01
0.00
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
106
1.04
0.00
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
252
0.99
0.00
1.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
111
0.99
0.00
2.9
2.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
151
0.99
0.00
1.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
105
1.05
0.00
2.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
255
0.98
0.00
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
55
0.91
0.00
1.2
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
6
64
0.94
0.00
1.2
1.1
nmol/l
345.3
409.5
—
6
59
(3035320) C reactive protein [Mass/volume] in Body fluid
5
52
0.96
0.00
2.6
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
82
0.98
0.00
1.0
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
84
0.95
0.00
2.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
86
0.93
0.00
1.6
1.4
nmol/l
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
60
1.00
0.00
1.2
2.9
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
79
1.01
0.00
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
12.0
—
0
6
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
2.4
—
136.2
—
0
5
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
66
0.91
0.00
1.5
1.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
4.9
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
36.0
—
0
6
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.3
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.1
—
0
5
(3025130) Human papilloma virus identified in Specimen
13
130
1.00
0.00
2.1
1.8
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
59
0.85
0.00
2.0
1.9
—
49.8
—
0
5
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint M13_BONEDENSOTH and mortality.

Females

Parameter HR [95% CI] p-value
M13_BONEDENSOTH 1.323 [1.12, 1.56] < 0.001
Birth year 0.995 [0.99, 1.01] 0.332

During the follow-up period (1.1.1998 — 31.12.2019), 397 out of 3559 females with M13_BONEDENSOTH died.

Males

Parameter HR [95% CI] p-value
M13_BONEDENSOTH 1.259 [1.08, 1.47] 0.004
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 307 out of 2959 males with M13_BONEDENSOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_BONEDENSOTH.

N-year risk Females Males
1 0.162% 0.24%
5 0.766% 1.641%
10 1.882% 3.791%
15 3.928% 7.102%
20 6.893% 11.974%

Relationships between endpoints

↥

Index endpoint: M13_BONEDENSOTH – Other disorders of bone density and structure

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data